Alkermes reports data from Phase Ib narcolepsy treatment trial

cafead

Administrator
Staff member
  • cafead   Apr 10, 2024 at 06:02: PM
via Alkermes has shared positive topline data from the narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) cohorts of a Phase Ib study of ALKS 2680 as a potential once-daily treatment for narcolepsy.

article source